GILEAD SCIENCES, INC.: 13F holdings
CIK 8820952026Q2
| Positions | 5 |
|---|
| Reported value | $1.6bn |
|---|
| Filed | 2026-08-03 |
|---|
Change since last quarter
| Positions | 5 (-1 vs prior quarter) |
|---|
| Reported value | $1.6bn (-22.1%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| RCUS Arcus Biosciences Inc. | 31,424,760 | $968.8m | 58.8% |
| LKFT Lakefront Biotherapeutics | 16,707,477 | $500.2m | 30.3% |
| Assembly Biosciences Inc. | 4,977,089 | $136.8m | 8.3% |
| KYTX Kyverna Therapeutics Inc. | 4,126,119 | $36.8m | 2.2% |
| Xilio Therapeutics Inc. | 650,389 | $6.2m | 0.4% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="882095")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples